Bosmon 62.5mg Tab
Bosmon 62.5mg Tab contains Bosentan — a dual ETA/ETB endothelin receptor antagonist for pulmonary arterial hypertension (PAH), reducing pulmonary vascular resistance and improving exercise capacity. Prescription-only specialist medicine requiring monthly liver function test (LFT) monitoring throughout therapy and strict contraception measures due to teratogenicity. Initiation dose: 62.5mg twice daily for 4 weeks, then escalate to 125mg twice daily maintenance dose.
Pay in 3 Installments of
Rs.
713
Bosmon 62.5mg Tab
Description
What is Bosmon 62.5mg Tab?
Bosmon 62.5mg Tab contains Bosentan — a dual endothelin receptor antagonist (ERA) that blocks both ETA and ETB receptors. It is a prescription-only medication used for the treatment of pulmonary arterial hypertension (PAH — WHO Group I), a serious condition of high blood pressure in the lung arteries. Available from Derma.pk as part of specialist medicines.
How Does Bosmon 62.5mg Work?
Endothelin-1 is a potent vasoconstrictor peptide overexpressed in PAH. Bosentan competitively blocks both ETA receptors (primarily on vascular smooth muscle, causing vasoconstriction and proliferation) and ETB receptors (on endothelium). By blocking endothelin signalling at both receptor subtypes, Bosmon reduces pulmonary vascular resistance, lowers pulmonary artery pressure, and slows vascular remodelling.
Uses of Bosmon 62.5mg
Treatment of PAH (idiopathic, heritable, connective tissue disease-associated, or congenital heart disease-associated) to improve exercise capacity and delay clinical worsening. Also used in systemic sclerosis-related PAH.
Dosage & Administration
Initiation dose: 62.5mg twice daily for 4 weeks (morning and evening). Maintenance dose: 125mg twice daily thereafter. Take with or without food at regular 12-hour intervals. Do not discontinue abruptly — taper under medical supervision. Consult your specialist physician for full dosing protocol.
Side Effects
Common: headache, nasopharyngitis, flushing, ankle oedema, anaemia. Serious: hepatotoxicity — liver enzymes (ALT/AST) must be tested monthly throughout therapy; dose reduction or discontinuation required if enzymes exceed 3x ULN. Fluid retention and decreased haematocrit may occur.
Precautions
Prescription required with strict monitoring. Monthly liver function tests (LFTs) are mandatory. Highly teratogenic — Category X in pregnancy: two reliable methods of contraception required; pregnancy test before initiation and monthly thereafter. CYP3A4 and CYP2C9 inducer — significant drug interactions (reduces cyclosporine, glibenclamide, sildenafil levels; increases warfarin metabolism). Contraindicated with cyclosporine and glibenclamide. Not for use in moderate-to-severe hepatic impairment.
Frequently Asked Questions
Q: Why are monthly liver tests required with Bosmon?
A: Bosentan can cause dose-dependent hepatotoxicity. Monthly ALT/AST monitoring is mandatory to detect liver injury early and adjust or stop therapy before serious damage occurs.
Q: Why must women use two forms of contraception on Bosmon?
A: Bosentan is teratogenic — it causes birth defects. Two reliable contraceptive methods plus monthly pregnancy testing are required for all women of childbearing potential taking this drug.
Q: Why start at 62.5mg twice daily?
A: The lower initiation dose allows the liver to adapt and tolerability to be established before escalating to the full 125mg twice daily maintenance dose after 4 weeks.
Usage & Benefits
- Blocks endothelin-1 at both ETA and ETB receptors, reducing pulmonary artery pressure
- Improves exercise capacity and quality of life in PAH patients
- Delays clinical worsening and disease progression in PAH
- Relieves breathlessness, fatigue, and effort intolerance
- Lower initiation dose (62.5mg) reduces hepatotoxicity risk vs starting at 125mg
- Evidence-based therapy for idiopathic, connective tissue, and congenital PAH
How To Use
Take Bosmon 62.5mg Tab exactly as prescribed by your specialist.
Initiation: 62.5mg twice daily (morning and evening) for 4 weeks.
Maintenance: 125mg twice daily thereafter (as directed by your doctor).
Take with or without food at consistent 12-hour intervals.
Do not stop abruptly — taper only under medical supervision.
Monthly liver function tests (LFTs) are mandatory throughout treatment.
FAQs
Why are monthly liver tests mandatory with Bosmon?
Bosentan causes dose-dependent hepatotoxicity. Monthly ALT/AST monitoring is required to detect liver injury early. Dose must be reduced or stopped if enzymes exceed 3 times the upper limit of normal.
Why is strict contraception required with Bosmon?
Bosentan is Category X teratogen — it causes serious birth defects. Two reliable contraceptive methods plus monthly pregnancy testing are mandatory for all women of childbearing potential.
Why start at 62.5mg and not the full dose?
The initiation dose allows the body (especially the liver) to adapt to bosentan before escalating to the 125mg twice daily maintenance dose after 4 weeks.
Dermatologist Recommended
Healer's Pharma Minoxidil 5% + Finasteride 0.25% Hair Regrowth Spray
0.25% Finasteride Topical Hair Loss Spray by Healer's Pharma
